Last update 27 May 2025

Retgliptin/Metformin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
瑞格列汀二甲双胍, HRX 0701, HRX-0701
+ [2]
Target
DPP-4
Action
inhibitors
Mechanism
DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
Diabetes Mellitus, Type 2
Inactive Indication-
Originator Organization
Shandong Suncadia Medicine Co., Ltd.
Active Organization
Shandong Suncadia Medicine Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
China (20 May 2025),
Diabetes Mellitus, Type 2
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC19H21F6N4O7P
InChIKeySFNHOWDAQMIJPX-HNCPQSOCSA-N
CAS Registry1256756-88-3
View All Structures (2)

Related

1
Clinical Trials associated with Retgliptin/Metformin
NCT05415644
/ CompletedPhase 1
Study of the Bioequivalence and Food Effects of HRX0701 Tablets in Healthy Subjects
100 Clinical Results associated with Retgliptin/Metformin
Login to view more data
100 Translational Medicine associated with Retgliptin/Metformin
Login to view more data
100 Patents (Medical) associated with Retgliptin/Metformin
Login to view more data
100 Deals associated with Retgliptin/Metformin
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2
China
Shandong Suncadia Medicine Co., Ltd.
20 May 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free